Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 5626
117th Congress(2021-2022)
SAFE Biomedical Research Act
Introduced
Introduced
Introduced in House on Oct 19, 2021
Overview
Text
Introduced in House 
Oct 19, 2021
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Oct 19, 2021)
Oct 19, 2021
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 5626 (Introduced-in-House)


117th CONGRESS
1st Session
H. R. 5626


To amend title IV of the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to consult with certain heads of Federal agencies with respect to biomedical research that may affect national security, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

October 19, 2021

Mr. Joyce of Pennsylvania introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend title IV of the Public Health Service Act to require the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to consult with certain heads of Federal agencies with respect to biomedical research that may affect national security, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Securing And Fortifying Everyday Biomedical Research Act” or the “SAFE Biomedical Research Act”.

SEC. 2. Duties of the Director.

Section 402(b) of the Public Health Service Act (42 U.S.C. 282(b)) is amended—

(1) in paragraph (24), by striking “; and” and inserting a semicolon;

(2) in paragraph (25)(B), by striking the period and inserting a semicolon; and

(3) by inserting after paragraph (25) the following:

“(26) shall consult with the Director of the Office of National Security within the Department of Health and Human Services, the Assistant Secretary for Preparedness and Response, the Director of National Intelligence, the Director of the Federal Bureau of Investigation, and the heads of other appropriate agencies on a regular basis, regarding biomedical research conducted or supported by the National Institutes of Health that may affect or be affected by matters of national security; and

“(27) shall ensure that recipients of awards from the National Institutes of Health, and, as appropriate and practicable, entities collaborating with such recipients, have in place and are adhering to appropriate technology practices and policies for the security of identifiable, sensitive information, including information collected, stored, or analyzed by domestic and foreign entities.”.